Serdar Durdagi
Affiliations: | Bahcesehir University, School of Medicine, Department of Biophysics |
Area:
computer-aided drug design, virtual screening, molecular docking, MD simulations, protein engineering, computational modeling, protein-protein and protein-ligand interactionsGoogle:
"Serdar Durdagi"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Haddad S, Oktay L, Erol I, et al. (2023) Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-Based Classifiers. Acs Omega. 8: 40864-40877 |
| Aksoydan B, Durdagi S. (2022) Virtual drug repurposing study for the CGRPR identifies pentagastrin and leuprorelin as putative candidates. Journal of Molecular Graphics & Modelling. 116: 108254 |
| DurdaĞi S. (2020) Virtual drug repurposing study against SARS-CoV-2 TMPRSS2 target. Turkish Journal of Biology = Turk Biyoloji Dergisi. 44: 185-191 |
| Turan RD, Albayrak E, Uslu M, et al. (2020) Development of Small Molecule MEIS Inhibitors that modulate HSC activity. Scientific Reports. 10: 7994 |
| Sahin K, Durdagi S. (2020) Identifying new piperazine-based PARP1 inhibitors using text mining and integrated molecular modeling approaches. Journal of Biomolecular Structure & Dynamics. 1-10 |
| Gunay BC, Yurtsever M, Durdagi S. (2019) Elucidation of interaction mechanism of hERG1 potassium channel with scorpion toxins BeKm-1 and BmTx3b. Journal of Molecular Graphics & Modelling. 96: 107504 |
| Ikram S, Ahmad J, Durdagi S. (2019) Screening of FDA approved drugs for finding potential inhibitors against Granzyme B as a potent drug-repurposing target. Journal of Molecular Graphics & Modelling. 107462 |
| Sahin K, Zengin Kurt B, Sonmez F, et al. (2019) Novel AChE and BChE Inhibitors Using Combined Virtual Screening, Text mining and In Vitro Binding Assays. Journal of Biomolecular Structure & Dynamics. 1-24 |
| Erol I, Aksoydan B, Kantarcioglu I, et al. (2018) Application of Multiscale Simulation Tools on GPCRs. An Example with Angiotensin II Type 1 Receptor. Methods in Molecular Biology (Clifton, N.J.). 1824: 431-448 |
| Aksoydan B, Kantarcioglu I, Erol I, et al. (2018) Structure-based design of hERG-neutral antihypertensive oxazalone and imidazolone derivatives. Journal of Molecular Graphics & Modelling. 79: 103-117 |